CBUS vs DOLE
CBUS: Cibus is a gene-editing biotechnology company that licenses proprietary agricultural productivity traits and develops sustainable plant-based ingredients for the global seed and consumer markets. DOLE: Dole plc is a global leader in fresh fruit and vegetable distribution, delivering a wide range of produce to international markets through an integrated supply chain.
Side-by-side fundamentals
| Metric | CBUS | DOLE | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $1.81 | $14.05 | |
| Market cap as of 2026-07-31 | $147M | $1.3B | |
| P/E as of 2026-07-31 | n/a | 31.16 | |
| PEG as of 2026-07-31 | n/a | 2.36 | |
| Net margin as of 2026-07-31 | -2366.3% | +0.5% | DOLE higher |
| Gross margin as of 2026-07-31 | +100.0% | +7.6% | CBUS higher |
| Operating margin as of 2026-07-31 | -1588.4% | +2.4% | DOLE higher |
| ROE as of 2026-07-31 | -225.6% | +3.2% | DOLE higher |
| ROA as of 2026-07-31 | -31.1% | +1.0% | DOLE higher |
| Debt / equity as of 2026-07-31 | 6.89 | 0.67 | DOLE lower |
| Revenue growth (YoY) as of 2026-07-31 | -9.8% | +11.4% | DOLE higher |
| Revenue CAGR (3y) SEC XBRL | +185.1% | +5.5% | CBUS higher |
| Dividend yield as of 2026-07-31 | n/a | +2.4% | |
| Dividend streak (yrs) SEC XBRL | n/a | 3 | |
| Beta as of 2026-07-31 | 1.61 | 0.64 | |
| 1-year return as of 2026-07-27 close | +12.4% | -2.5% | CBUS higher |
Fundamentals: market data, as of 2026-07-31. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.